Gamma glutamyl transferase (GGT) levels are an important clinical marker for assessing liver health and risk of metabolic disease. Factors such as genetics, alcohol consumption, certain medications, obesity, and metabolic conditions such as type 2 diabetes can influence GGT levels. Understanding these factors is essential for accurate assessment and proper management of GGT-related health conditions.
Gamma glutamyl transferase levels
Gamma glutamyl transferase (GGT) is an enzyme that plays a crucial role in glutathione metabolism and in the transfer of amino acids across cell membranes. This enzyme is found in several organs of the body, but is especially abundant in the liver. Measurement of GGT levels in the blood is an important tool in clinical medicine to assess liver health and biliary function. Elevated serum GGT levels may indicate liver damage, biliary obstruction, excessive alcohol consumption, and chronic liver diseases such as cirrhosis and hepatitis.
GGT levels can be influenced by a variety of factors, both exogenous and endogenous. Among the exogenous factors, alcohol consumption is one of the most significant. Alcohol abuse can increase GGT levels considerably, sometimes even before other markers of liver damage are altered. In addition, certain medications, such as anticonvulsants and antidepressants, can elevate GGT levels due to their effect on hepatic enzyme induction.
Among endogenous factors, obesity and metabolic syndrome are frequently associated with elevated GGT levels. These states are linked to increased inflammation and oxidative stress, which can stimulate GGT production. In addition, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) are conditions that can also elevate GGT levels due to associated liver damage.
Number of observed variants
13.5 million variants
Number of risk loci
556 loci
Genes analyzed
Bibliography
Barton A.R., Sherman M.A., et al. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nature Genetics, 05 Jul 2021, 53(8):1260-1269.
van Beek J.H.D.A., de Moor M.H.M., et al. The Genetic Architecture of Liver Enzyme Levels: GGT, ALT and AST. Behav Genet. 2013 Jul; 43(4): 329-339.
